Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
MAP3K4 Blocking Peptide (AC1276)
Cat.#: ACPP-1276
Specifications
Despition MAP3K4 Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1440 Human SIRPA Protein (AC1440) 5 µg inquiry ACPP-1738 Human PNOC Protein (AC1738) 5 µg inquiry ACPP-1498 Human LIN7A Protein (AC1498) 2 µg inquiry ACPP-1622 Human DLK1 Protein (AC1622) 2 µg inquiry ACPP-1031 Recombinant Human CD24 Protein (Fc Tag) (AC1031) 50 µg inquiry ACPP-1832 Human CRYZ Protein (AC1832) 5 µg inquiry ACPP-1143 Recombinant Human Adenosine Receptor A2a Protein (Fc Tag) (AC1143) 50 µg inquiry ACPP-1387 Human ARC Protein (AC1387) 1 µg inquiry ACPP-1355 MERTK Blocking Peptide (AC1355) 250 µg inquiry ACPP-1510 Human TIMP1 Protein, Sf9 (AC1510) 2 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket